New Zealand markets open in 2 hours 46 minutes

Jiangsu CoWin Biotech Co., Ltd. (688426.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
18.66+0.60 (+3.32%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.03B
Enterprise value 1.21B
Trailing P/E 18.68
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.97
Price/book (mrq)1.25
Enterprise value/revenue 9.84
Enterprise value/EBITDA 18.49

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-39.36%
S&P500 52-week change 324.96%
52-week high 338.16
52-week low 314.02
50-day moving average 319.31
200-day moving average 325.39

Share statistics

Avg vol (3-month) 3383.76k
Avg vol (10-day) 3325.17k
Shares outstanding 5112.49M
Implied shares outstanding 6112.49M
Float 838.19M
% held by insiders 171.67%
% held by institutions 111.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.52
Forward annual dividend yield 42.85%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4202.60%
Dividend date 3N/A
Ex-dividend date 412 Jun 2023
Last split factor 21.2:1
Last split date 312 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -95.26%
Operating margin (ttm)-140.59%

Management effectiveness

Return on assets (ttm)-6.29%
Return on equity (ttm)-7.11%

Income statement

Revenue (ttm)123.2M
Revenue per share (ttm)1.12
Quarterly revenue growth (yoy)-62.60%
Gross profit (ttm)N/A
EBITDA -161.08M
Net income avi to common (ttm)-117.37M
Diluted EPS (ttm)-1.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)850.56M
Total cash per share (mrq)7.63
Total debt (mrq)30.86M
Total debt/equity (mrq)1.88%
Current ratio (mrq)14.87
Book value per share (mrq)14.63

Cash flow statement

Operating cash flow (ttm)-31.97M
Levered free cash flow (ttm)-154.21M